The second episode of The Leaders’ Room season two features Regeneron Ireland lead, Muriel O’Byrne. The Leaders’ Room podcast features interviews with the country managers of some of Ireland ...
More than 150,000 customers are without power in the Republic of Ireland, as crews continue to repair "unprecedented" damage to the electricity network caused by Storm Éowyn. Friday's storm ...
Ireland has joined South Africa’s genocide case against Israel, the International Court of Justice announced Tuesday morning. In a brief press statement, the ICJ said that Ireland had on Monday ...
After Regeneron Chief Scientific Officer George Yancopoulos, M.D., Ph.D., spent more than 25 minutes waxing about the company’s deep pipeline Monday at the J.P. Morgan Healthcare Conference ...
Illumina and Regeneron are taking stakes in health data company Truveta to help fund research that may dwarf the efforts of the National Institutes of Health’s All of Us million-person program ...
The six counties in Northern Ireland also remains under a yellow warning for snow and ice, per the UK’s Met Office. The bad weather is continuing to affect the criminal justice system ...
Regeneron stock has trended bearishly since August, but growth in LIBTAYO and DUPIXENT offers a promising outlook, prompting a BUY rating. EYLEA HD's success mitigates biosimilar competition ...
Regeneron collaborates with Truveta and leading American health systems to massively extend its DNA-linked healthcare database to further advance scientific innovation and healthcare delivery ...
In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) stands against other best depressed stocks to invest in now. The US stocks ended 2024 with a ...
Ahead of the new League of Ireland season, Gavin Cummiskey updates us on the efforts of teams with title aspirations to recruit centre forwards capable of knocking in a heap of goals, while in ...
Regeneron Pharmaceuticals, Inc. (REGN) Securities Class Action: The litigation is focused on the propriety of Regeneron’s statements about its compliance with applicable rules and regulations ...